Target intelligence / Profile preview

TWIK-related potassium channel (TREK) (TREK)

Target
TREK
Molecular classification
Ion channel, Two-pore domain potassium channel
01

Overview

TWIK-related potassium channels (TREK), including TREK-1, TREK-2, and TRAAK, are members of the two-pore domain potassium (K2P) channel family that play a fundamental role in regulating the resting membrane potential and neuronal excitability [UniProt]. These channels are unique for their polymodal gating, as they are activated by a diverse array of stimuli including mechanical stretch, heat, intracellular acidification, and polyunsaturated fatty acids like arachidonic acid [PubMed: 25817450]. In the central nervous system, TREK channels act as inhibitory brakes on neuronal activity, and their dysfunction is linked to various neurological and psychiatric conditions such as major depressive disorder, chronic pain, and epilepsy [PubMed: 16691240]. TREK-1, in particular, has emerged as a promising target for rapidly acting antidepressants, as its inhibition mimics the effects of chronic SSRI treatment [PubMed: 20434928]. Furthermore, these channels are sensitive to volatile general anesthetics and neuroprotective agents like riluzole, highlighting their clinical relevance in anesthesia and stroke management [StatPearls]. Developing selective modulators for TREK channels remains a significant therapeutic goal, though challenges exist regarding tissue specificity and potential off-target effects in the cardiovascular system [PubMed: 28655116].

Other names
K2P channelTwo-pore domain potassium channelKCNK channelTREK-1TREK-2TRAAKKCNK2KCNK10KCNK4
02

Mechanism of action

Modulation of potassium efflux to regulate resting membrane potential and neuronal excitability; activators induce hyperpolarization while inhibitors induce depolarization [PubMed: 25817450].

03

Biological functions

Resting membrane potential regulationMechanosensationThermosensationNeuroprotectionLipid sensing
04

Disease associations

Major depressive disorderChronic painIschemiaEpilepsyCardiac arrhythmia
05

Safety considerations

Cardiac conduction disturbancesGastrointestinal motility changesPotential for seizures with excessive inhibitionHypotension with systemic activation
06

Interacting drugs

Fluoxetine

6 more in the full profile.

07

Biomarkers

KCNK2 mRNA expressionKCNK2 protein levels

Beyond the preview

Go deeper on TWIK-related potassium channel (TREK) (TREK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TWIK-related potassium channel (TREK) (TREK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call